Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute.
Zeidner, Joshua F
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute. [electronic resource] - Journal of the National Cancer Institute Mar 2016
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1460-2105
10.1093/jnci/djv335 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Clinical Trials, Phase I as Topic
Female
Humans
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged
National Cancer Institute (U.S.)
Odds Ratio
Patient Selection
Retrospective Studies
Survival Analysis
Treatment Outcome
United States--epidemiology
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute. [electronic resource] - Journal of the National Cancer Institute Mar 2016
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1460-2105
10.1093/jnci/djv335 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Clinical Trials, Phase I as Topic
Female
Humans
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged
National Cancer Institute (U.S.)
Odds Ratio
Patient Selection
Retrospective Studies
Survival Analysis
Treatment Outcome
United States--epidemiology